Long-Term Survival of Patients With Ischemic Cardiomyopathy Treated by Coronary Artery Bypass Grafting Versus Medical Therapy Eric J. Velazquez, MD,

Slides:

Advertisements

Similar presentations

Peter K. Smith, MD, Robert M. Califf, MD, Robert H

Advertisements

Insights from the STICH trial: Change in left ventricular size after coronary artery bypass grafting with and without surgical ventricular reconstruction

Results of Coronary Artery Endarterectomy and Coronary Artery Bypass Grafting for Diffuse Coronary Artery Disease Srikrishna Sirivella, MD, Isaac Gielchinsky,

Impact of Chronic Kidney Disease on Long-Term Outcomes in Type 2 Diabetic Patients With Coronary Artery Disease on Surgical, Angioplasty, or Medical Treatment

Elevated Preoperative Hemoglobin A1c Level is Associated With Reduced Long-Term Survival After Coronary Artery Bypass Surgery Michael E. Halkos, MD,

Elevated Hemoglobin A1c Is Associated With Lower Socioeconomic Position and Increased Postoperative Infections and Longer Hospital Stay After Cardiac.

Is Hospital Procedure Volume a Reliable Marker of Quality for Coronary Artery Bypass Surgery? A Comparison of Risk and Propensity Adjusted Operative and.

Coronary Artery Bypass for Heart Failure in Ischemic Cardiomyopathy: 17-Year Follow- Up Marco Pocar, MD, PhD, Andrea Moneta, MD, Adalberto Grossi, MD,

Manuel Caceres, MD, Darryl S. Weiman, MD, JD

Cyrus J. Parsa, MD, Linda K. Shaw, MS, J. Scott Rankin, MD, Mani A

Leena Khaitan, MD, Francis P Sutter, Scott M Goldman, MD

Long-Term Outcome of Coronary Artery Bypass Grafting in Patients With Left Ventricular Dysfunction Paolo Nardi, MD, PhD, Antonio Pellegrino, MD, Antonio.

Elevated Hemoglobin A1c Is Associated With Lower Socioeconomic Position and Increased Postoperative Infections and Longer Hospital Stay After Cardiac.

Jeevan Nagendran, MD, Colleen M. Norris, PhD, Michelle M

Intraoperative Conversion From Off-Pump to On-Pump Coronary Artery Bypass Is Associated With Increased 30-Day Hospital Readmission Zhongmin Li, PhD,

Coronary artery bypass grafting in patients with advanced left ventricular dysfunction Gregory D Trachiotis, MD, William S Weintraub, MD, Thomas S Johnston,

Revascularization of Left Anterior Descending Artery With Drug-Eluting Stents: Comparison With Off-Pump Surgery Itzhak Herz, MD, Yaron Moshkovitz, MD,

Unprotected Left Main Coronary Artery Stenting Versus Coronary Artery Bypass Graft Surgery Hisato Takagi, MD, PhD, Hideaki Manabe, MD, Norikazu Kawai,

Peter K. Smith, MD The Journal of Thoracic and Cardiovascular Surgery

Valve Replacement for Severe Aortic Stenosis With Low Transvalvular Gradient and Left Ventricular Ejection Fraction Exceeding 0.50 Giuseppe Tarantini,

Long-Term Consequences of Postoperative Heart Failure After Surgery for Aortic Stenosis Compared With Coronary Surgery Farkas B. Vánky, MD, PhD, Erik.

Peter K. Smith, MD The Annals of Thoracic Surgery

J. Trevor Posenau, MD, Daniel M. Wojdyla, MS, Linda K

Insights from the STICH trial: Change in left ventricular size after coronary artery bypass grafting with and without surgical ventricular reconstruction

Comparing Long-Term Survival Between Patients Undergoing Off-Pump and On-Pump Coronary Artery Bypass Graft Operations Giovanni Filardo, PhD, MPH, Paul.

The Impact of Peripheral Vascular Disease on Long-Term Survival After Coronary Artery Bypass Graft Surgery Danny Chu, MD, Faisal G. Bakaeen, MD, Xing.

Elevated Preoperative Hemoglobin A1c Level is Associated With Reduced Long-Term Survival After Coronary Artery Bypass Surgery Michael E. Halkos, MD,

Sequential Radial Artery Grafts for Multivessel Coronary Artery Bypass Graft Surgery: 10-Year Survival and Angiography Results Thomas A. Schwann, MD,

Management of High-Risk Patients With Aortic Stenosis and Coronary Artery Disease Daniel Wendt, MD, Philipp Kahlert, MD, Tim Lenze, Markus Neuhäuser,

Juan A. Crestanello, MD, Richard C. Daly, MD

Three-Year Outcomes of Multivessel Revascularization in Very Elderly Acute Coronary Syndrome Patients Brett C. Sheridan, MD, Sally C. Stearns, PhD, Joseph.

New-Onset Postoperative Atrial Fibrillation and Long-Term Survival After Aortic Valve Replacement Surgery Giovanni Filardo, PhD, MPH, Cody Hamilton,

Zhe Zheng, MD, PhD, Heng Zhang, MD, PhD, Bo Xu, MBBS

Long-Term Mortality of Coronary Artery Bypass Graft Surgery and Stenting With Drug- Eluting Stents Chuntao Wu, MD, PhD, Fabian T. Camacho, MS, Songyang.

Donald S. Likosky, PhD, Stephen D. Surgenor, MD, Robert S

Impact of Extracardiac Vascular Disease on Vein Graft Failure and Outcomes After Coronary Artery Bypass Surgery Ralf E. Harskamp, MD, John H. Alexander,

Established Preoperative Risk Factors Do Not Predict Long-Term Survival in Isolated Coronary Artery Bypass Grafting Patients Giovanni Filardo, PhD, MPH,

Mariano E. Brizzio, MD, Alex Zapolanski, MD, Richard E

Predictors of Low Cardiac Output Syndrome After Isolated Coronary Artery Bypass Surgery: Trends Over 20 Years Khaled D. Algarni, MD, MHS, Manjula Maganti,

Long-term survival benefits of coronary artery bypass grafting and percutaneous transluminal angioplasty in patients with coronary artery disease Robert.

Right Ventricular Systolic Dysfunction Assessed by Cardiac Magnetic Resonance Is a Strong Predictor of Cardiovascular Death After Coronary Bypass Grafting

Percutaneous Intervention Before Coronary Artery Bypass Surgery Does Not Unfavorably Impact Survival: A Single-Center Propensity-Matched Analysis Suvitesh.

A decade after the Surgical Treatment for Ischemic Heart Failure (STICH) trial: Weaving firm clinical recommendations from lessons learned Robert E.

Bartosz Rylski, MD, Nimesh D. Desai, MD, PhD, Joseph E

Sajjad Raza, MD, Joseph F. Sabik, MD, Stephen G. Ellis, MD, Penny L

Matthew J. Bott, MD, Hanghang Wang, BA, William Travis, MD, Gregory J

Role of Surgical Ventricular Restoration in the Treatment of Ischemic Cardiomyopathy Jun Liu, MD, Zixiong Liu, MD, Qiang Zhao, MD, Anqing Chen, MD, Zhe.

Effect of blood transfusion on long-term survival after cardiac operation Milo C Engoren, MD, Robert H Habib, PhD, Anoar Zacharias, MD, Thomas A Schwann,

Peter K. Smith, MD, Robert M. Califf, MD, Robert H

A. Laurie W. Shroyer, PhD, MSHA, Jacquelyn A. Quin, MD, MPH, Todd H

Aortic Valve Replacement for Patients With Severe Aortic Stenosis: Risk Factors and Their Impact on 30-Month Mortality Edward L. Hannan, PhD, Zaza Samadashvili,

Current Clinical Outcomes of Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting Michael J. Mack, MD, Syma L. Prince, RN, Morley Herbert,

Mitral Valve Repair for Degenerative Disease: A 20-Year Experience

Stent Versus Off-Pump Coronary Bypass Grafting in the Second-Generation Drug- Eluting Stent Era Gijong Yi, MD, PhD, Hyun-Chel Joo, MD, Young-Nam Youn,

Early and Midterm Results of Off-Pump Coronary Artery Bypass Grafting

Limitations of Hospital Volume as a Measure of Quality of Care for Coronary Artery Bypass Graft Surgery Karl F. Welke, MD, Mitchell J. Barnett, PharmD,

Survival After Isolated Coronary Artery Bypass Grafting in Patients With Severe Left Ventricular Dysfunction Waleed A. Ahmed, MD, Phillip J. Tully, BHSc(Hons),

Trends in Patient Characteristics and Outcomes of Coronary Artery Bypass Grafting in the 2000 to 2012 Medicare Population Christian McNeely, MD, Stephen.

Left Ventricular Reconstruction Benefits Patients With Dilated Ischemic Cardiomyopathy Atsushi Yamaguchi, MD, Hideo Adachi, MD, Koji Kawahito, MD, Seiichiro.

Total Arterial Off-Pump Coronary Surgery: Time to Change Our Habits?

On-Pump Versus Off-Pump Surgical Revascularization for Left Main Stem Stenosis: Risk Adjusted Outcomes John C.Y. Lu, Antony D. Grayson, BS, D. Mark Pullan

Improved Long-Term Survival for Diabetic Patients With Surgical Versus Interventional Revascularization Paul Kurlansky, MD, Morley Herbert, PhD, Syma.

Bilateral Internal Thoracic Artery Grafts in Hemodialysis: A Single-Center Propensity Score Analysis Yoshinori Nakahara, MD, Shigehiko Yoshida, MD, Takeyuki.

Kaplan-Meier estimate of mortality in the two treatment strategies with significant difference between the two groups (log-rank test

Lung Transplantation and Coronary Artery Disease

Impact of Diabetes on Five-Year Outcomes of Patients With Multivessel Coronary Artery Disease Whady Hueb, MD, Bernard J. Gersh, MB, ChB, Fernando Costa,

Utilization and Outcomes of Unprotected Left Main Coronary Artery Stenting and Coronary Artery Bypass Graft Surgery Chuntao Wu, MD, PhD, Edward L. Hannan,

Left Ventricular End-Diastolic Pressure Predicts Survival in Coronary Artery Bypass Graft Surgery Patients Jeevan Nagendran, MD, PhD, Colleen M. Norris,

Previous Percutaneous Coronary Interventions Increase Mortality and Morbidity After Coronary Surgery Vito Mannacio, MD, Luigi Di Tommaso, MD, Vincenzo.

Magnus Dalén, MD, Torbjörn Ivert, MD, PhD, Martin J

Presentation transcript:

Long-Term Survival of Patients With Ischemic Cardiomyopathy Treated by Coronary Artery Bypass Grafting Versus Medical Therapy Eric J. Velazquez, MD, Judson B. Williams, MD, Eric Yow, MS, Linda K. Shaw, MS, Kerry L. Lee, PhD, Harry R. Phillips, MD, Christopher M. O'Connor, MD, Peter K. Smith, MD, Robert H. Jones, MD The Annals of Thoracic Surgery Volume 93, Issue 2, Pages 523-530 (February 2012) DOI: 10.1016/j.athoracsur.2011.10.064 Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Identification of study cohort from all patients undergoing cardiac catheterization at Duke Medical Center January 1, 1995, through July 31, 2009, and treated with medical therapy (MED) or coronary artery bypass grafting (CABG). (CAD = coronary artery disease; CCS = Canadian Cardiovascular Society; LVEF = left ventricular ejection fraction; PCI = percutaneous coronary intervention.) The Annals of Thoracic Surgery 2012 93, 523-530DOI: (10.1016/j.athoracsur.2011.10.064) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Propensity quintiles for selecting medical therapy (MED) at Duke 1995–2005. Total patients and mortality are presented for each quintile. (CABG = coronary artery bypass grafting.) The Annals of Thoracic Surgery 2012 93, 523-530DOI: (10.1016/j.athoracsur.2011.10.064) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Unadjusted Kaplan-Meier estimates of time to death in all study patients (propensity quintiles I–V). (CABG = coronary artery bypass grafting.) The Annals of Thoracic Surgery 2012 93, 523-530DOI: (10.1016/j.athoracsur.2011.10.064) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions

Fig 4 Unadjusted (A) and risk-adjusted (B) Kaplan-Meier rate estimates of time to death in 395 patients with similar propensity (quintiles I–III) for medical therapy. (CABG = coronary artery bypass grafting.) The Annals of Thoracic Surgery 2012 93, 523-530DOI: (10.1016/j.athoracsur.2011.10.064) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions

Fig 5 Unadjusted Kaplan-Meier rate estimates of time to death for Surgical Treatment for Ischemic Heart Failure (STICH) trial and Duke Databank for Cardiovascular Disease (DDCD) patients. (CABG = coronary artery bypass grafting.) The Annals of Thoracic Surgery 2012 93, 523-530DOI: (10.1016/j.athoracsur.2011.10.064) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions